COMPARATIVE ANALYSIS OF THE COURSE OF CHRONIC KIDNEY DISEASE (CKD) IN PATIENTS WITH DIFFERENT STAGES OF RENAL CANCER AFTER RADICAL AND CYTOREDUCTIVE NEPHRECTOMY
Renal cell carcinoma (RCC) ranks tenth in terms of the incidence rate among all malignant diseases and amounts to 2 %. In 30 % of newly diagnosed cases of RCC, the presence of distant metastases is diagnosed, and the life expectancy of this group of patients does not exceed 12 months from the time o...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Ukrainian |
| Published: |
Ukrmedknyha Publishing House
2017-11-01
|
| Series: | Vіsnik Naukovih Doslіdžen' |
| Subjects: | |
| Online Access: | https://ojs.tdmu.edu.ua/index.php/visnyk-nauk-dos/article/view/8088 |
| Summary: | Renal cell carcinoma (RCC) ranks tenth in terms of the incidence rate among all malignant diseases and amounts to 2 %. In 30 % of newly diagnosed cases of RCC, the presence of distant metastases is diagnosed, and the life expectancy of this group of patients does not exceed 12 months from the time of detection of the disease.
The aim of the study – to conduct a comparative analysis of the course of chronic kidney disease in patients at different stages of renal cell carcinoma after radical and cytodectile nephrectomy.
Materials and Methods. The study was attended by 53 patients with renal cell carcinoma (RCC) complicated by chronic kidney disease. All patients had a radical or cytoreductile nephrectomy for RCC, and a retrospective analysis of the treatment outcomes was performed thereafter. All patients undergo inpatient treatment in the Urological Department of the Lviv Regional Clinical Hospital and in the Urological Department of the Lviv Oncology Regional Treatment and Diagnostic Center.
Results and Discussion. Analyzing the data presented in Table 1, it can be noted that prior to the surgical treatment of kidney cancer, in 2 stages of the CKD, 9 (42. 9 %) patients in the first group and 23 (71. 9 %) patients in the second group. Accordingly, the 3rd stage of CKD was diagnosed in 7 (33.3 %) patients in the first group and in 7 (21. 9 %) patients in the second group. 3rd stage of CKD was observed in 4 (19.0 %) patients in the first group and in 2 (6.3 %) patients in the second group. At the fourth stage of the CKD, only 1 (4.8 %) patients in the first group underwent surgical treatment. The fifth stage of the CKD was not observed in any case. Analyzing the data presented in Table 2, it can be noted that three months after the surgical treatment of kidney cancer, progression of CKD was observed in 11 (52.4 %) patients in the first group and 9 (28.1 %) patients in the second group.
Conclusions. Carrying out cytoreductive nephrectomy in patients with RCC increases the risk of CKD progression by 24.3 % comparing with the implementation of radical nephrectomy. |
|---|---|
| ISSN: | 1681-276X 2415-8798 |